Shenzhen Lifotronic Technology Co (688389) - Total Liabilities

Latest as of March 2026: CN¥382.72 Million CNY ≈ $56.00 Million USD

Based on the latest financial reports, Shenzhen Lifotronic Technology Co (688389) has total liabilities worth CN¥382.72 Million CNY (≈ $56.00 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Shenzhen Lifotronic Technology Co (688389) net asset momentum to track the company's year-over-year net asset growth rate.

Shenzhen Lifotronic Technology Co - Total Liabilities Trend (2016–2025)

This chart illustrates how Shenzhen Lifotronic Technology Co's total liabilities have evolved over time, based on quarterly financial data. See 688389 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Shenzhen Lifotronic Technology Co Competitors by Total Liabilities

The table below lists competitors of Shenzhen Lifotronic Technology Co ranked by their total liabilities.

Company Country Total Liabilities
Jinxi Axle Co Ltd
SHG:600495
China CN¥760.99 Million
Qingdao Kutesmart Co Ltd
SHE:300840
China CN¥361.17 Million
Collins Foods Ltd
AU:CKF
Australia AU$1.05 Billion
Golden Friends
TWO:4506
Taiwan NT$5.59 Billion
Fujian MinDong Electric Power Co Ltd
SHE:000993
China CN¥981.01 Million
JDM Jingda Mach(Ningbo)Co Ltd
SHG:603088
China CN¥822.81 Million
Shenzhen Absen Optoelectronic Co Ltd
SHE:300389
China CN¥2.64 Billion
Amsterdam Commodities NV
AS:ACOMO
Netherlands €552.96 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Shenzhen Lifotronic Technology Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Shenzhen Lifotronic Technology Co.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.34 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shenzhen Lifotronic Technology Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shenzhen Lifotronic Technology Co (2016–2025)

The table below shows the annual total liabilities of Shenzhen Lifotronic Technology Co from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥700.79 Million
≈ $102.55 Million
-17.08%
2024-12-31 CN¥845.13 Million
≈ $123.67 Million
+58.34%
2023-12-31 CN¥533.76 Million
≈ $78.11 Million
+41.57%
2022-12-31 CN¥377.02 Million
≈ $55.17 Million
+74.14%
2021-12-31 CN¥216.50 Million
≈ $31.68 Million
+48.31%
2020-12-31 CN¥145.98 Million
≈ $21.36 Million
+12.91%
2019-12-31 CN¥129.29 Million
≈ $18.92 Million
-9.92%
2018-12-31 CN¥143.53 Million
≈ $21.00 Million
+16.56%
2017-12-31 CN¥123.15 Million
≈ $18.02 Million
-2.80%
2016-12-31 CN¥126.69 Million
≈ $18.54 Million
--

About Shenzhen Lifotronic Technology Co

SHG:688389 China Medical Devices
Market Cap
$680.31 Million
CN¥4.65 Billion CNY
Market Cap Rank
#10687 Global
#2892 in China
Share Price
CN¥10.85
Change (1 day)
-1.09%
52-Week Range
CN¥9.59 - CN¥14.74
All Time High
CN¥37.22
About

Shenzhen Lifotronic Technology Co., Ltd. research, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. The company offers IVD products, such as HPLC, ECLIA, and hematology system; rapid test, molecular and POCT diagnostics. It also offers therapeutic products comprising respiratory and ICU, and wound ca… Read more